» Articles » PMID: 34026845

SLC38A10 Transporter Plays a Role in Cell Survival Under Oxidative Stress and Glutamate Toxicity

Overview
Specialty Biology
Date 2021 May 24
PMID 34026845
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Solute carrier (SLC) transporters regulate amino acids, glucose, ions, and metabolites that flow across cell membranes. In the brain, SLCs are the key regulators of neurotransmission, in particular, the glutamate/GABA-glutamine (GGG) cycle. Genetic mutations in SLCs are associated with various neurodevelopmental and neurodegenerative diseases. In this study, we have investigated the role of SLC38A10 under acute oxidative and glutamate stress in mouse primary cortical cells from SLC38A10 knockout (KO) mice. The ER/golgi localized transporter, SLC38A10, transports glutamate, glutamine, and alanine in brain cells, and the aim of this study was to determine the possible effects of removal of SLC38A10 in primary cortical cells under glutamate and oxidative challenges. Primary cortical neuronal cultures of wild-type (WT) cell and SLC38A10 KO mice were subjected to different concentrations of glutamate and hydrogen peroxide. There was no morphological change observed between KO and WT cortical neurons in culture. Interestingly, KO cells showed significantly lower cell viability and higher cell death compared to WT cells under both glutamate and hydrogen peroxide exposure. Further, we evaluated the possible role of p53 in neuronal cell apoptosis in KO cells. We found decreased intracellular p53 protein levels under glutamate and hydrogen peroxide treatment in KO cortical cells. In contrast, caspase 3/7 activity remains unaltered under all conditions. These results demonstrate an indirect relationship between the expression of SLC38A10 and p53 and a role in the cell defense mechanism against neurotoxicity.

Citing Articles

Elevated Cerebrospinal Fluid Ubiquitin Carboxyl-Terminal Hydrolase Isozyme L1 in Asymptomatic C9orf72 Hexanucleotide Repeat Expansion Carriers.

Dellar E, Vendrell I, Amein B, Lester D, Edmond E, Yoganathan K Ann Neurol. 2024; 97(3):449-459.

PMID: 39548852 PMC: 11831881. DOI: 10.1002/ana.27133.


Transcriptomic and Proteomic Insights into Host Immune Responses in Pediatric Severe Malarial Anemia: Dysregulation in HSP60-70-TLR2/4 Signaling and Altered Glutamine Metabolism.

Onyango C, Anyona S, Hurwitz I, Raballah E, Wasena S, Osata S Pathogens. 2024; 13(10).

PMID: 39452740 PMC: 11510049. DOI: 10.3390/pathogens13100867.


PathVar: A Customisable NGS Variant Calling Algorithm Implicates Novel Candidate Genes and Pathways in Hemiplegic Migraine.

Alfayyadh M, Maksemous N, Sutherland H, Lea R, Griffiths L Clin Genet. 2024; 107(2):157-168.

PMID: 39394929 PMC: 11725560. DOI: 10.1111/cge.14625.


SLC38A10 Deficiency in Mice Affects Plasma Levels of Threonine and Histidine in Males but Not in Females: A Preliminary Characterization Study of SLC38A10 Mice.

Lindberg F, Nordenankar K, Forsberg E, Fredriksson R Genes (Basel). 2023; 14(4).

PMID: 37107593 PMC: 10138244. DOI: 10.3390/genes14040835.


Circular RNAs in the Origin of Developmental Lung Disease: Promising Diagnostic and Therapeutic Biomarkers.

Tong Y, Zhang S, Riddle S, Song R, Yue D Biomolecules. 2023; 13(3).

PMID: 36979468 PMC: 10046088. DOI: 10.3390/biom13030533.


References
1.
Koppula P, Zhang Y, Zhuang L, Gan B . Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer. Cancer Commun (Lond). 2018; 38(1):12. PMC: 5993148. DOI: 10.1186/s40880-018-0288-x. View

2.
Sundberg B, Waag E, Jacobsson J, Stephansson O, Rumaks J, Svirskis S . The evolutionary history and tissue mapping of amino acid transporters belonging to solute carrier families SLC32, SLC36, and SLC38. J Mol Neurosci. 2008; 35(2):179-93. DOI: 10.1007/s12031-008-9046-x. View

3.
Behrens P, Franz P, Woodman B, Lindenberg K, Landwehrmeyer G . Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation. Brain. 2002; 125(Pt 8):1908-22. DOI: 10.1093/brain/awf180. View

4.
Sheldon A, Robinson M . The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention. Neurochem Int. 2007; 51(6-7):333-55. PMC: 2075474. DOI: 10.1016/j.neuint.2007.03.012. View

5.
Coyle J, Puttfarcken P . Oxidative stress, glutamate, and neurodegenerative disorders. Science. 1993; 262(5134):689-95. DOI: 10.1126/science.7901908. View